Xiao Lena, Chen Anna, Parmar Arpita, Frankel Lucy, Toulany Alene, Murray Brian J, Narang Indra
Division of Respiratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.
Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.
Behav Sleep Med. 2022 Mar-Apr;20(2):260-268. doi: 10.1080/15402002.2021.1916496. Epub 2021 Apr 20.
Narcolepsy, characterized by excessive daytime sleepiness, is a debilitating lifelong sleep disorder for which there is no cure. Current pharmacological and nonpharmacological treatments directed toward symptom management may be suboptimal. This qualitative study explores the perspective of adolescents on therapeutic interventions for narcolepsy.
Semi-structured interviews with adolescents with narcolepsy were conducted from May to August 2019 at The Hospital for Sick Children in Toronto, Canada. Qualitative thematic analysis was utilized to generate themes emerging from the data.
Eighteen adolescents with narcolepsy (age range = 10-17, mean age = 14.4 ± 2.0 years, 72% male) participated and 56% had cataplexy. Four prominent themes arose regarding therapeutic interventions for narcolepsy. Firstly, participants described that pharmacotherapy was moderately effective but did not fully relieve symptoms associated with narcolepsy. Secondly, while medications are the first line treatment for narcolepsy, many participants reported frustration regarding medication dependence and side effects. Thirdly, nonpharmacological strategies including scheduled sleep times and exercise were accepted and often employed. Lastly, adolescents desired more psychosocial support to address mental health sequelae of narcolepsy that were not fully managed by current treatment modalities.
Medications were perceived as moderately effective for managing narcolepsy but almost all participants expressed concerns with taking medications due to side effects. Adolescents valued the importance of more holistic care for their narcolepsy treatment such as psychosocial support and nonpharmacological modalities. Further anticipatory guidance regarding pharmacological side effect profiles and better integration with nonpharmacological modalities are needed to improve disease control in adolescent patients.
发作性睡病的特征是白天过度嗜睡,是一种使人衰弱的终身性睡眠障碍,目前尚无治愈方法。目前针对症状管理的药物和非药物治疗可能并不理想。本定性研究探讨了青少年对发作性睡病治疗干预措施的看法。
2019年5月至8月,在加拿大多伦多病童医院对患有发作性睡病的青少年进行了半结构化访谈。采用定性主题分析法从数据中提炼出主题。
18名患有发作性睡病的青少年(年龄范围=10-17岁,平均年龄=14.4±2.0岁,72%为男性)参与了研究,56%的人有猝倒症状。关于发作性睡病的治疗干预措施出现了四个突出主题。首先,参与者表示药物治疗有一定效果,但并未完全缓解与发作性睡病相关的症状。其次,虽然药物是发作性睡病的一线治疗方法,但许多参与者报告了对药物依赖和副作用的不满。第三,包括规律睡眠时间和运动在内的非药物策略被接受并经常采用。最后,青少年希望获得更多心理社会支持,以解决发作性睡病的心理健康后遗症,而目前的治疗方式并未完全解决这些问题。
药物被认为对控制发作性睡病有一定效果,但几乎所有参与者都因副作用而对服药表示担忧。青少年重视对发作性睡病进行更全面治疗的重要性,如心理社会支持和非药物治疗方式。需要进一步提供有关药物副作用的预期指导,并更好地将其与非药物治疗方式相结合,以改善青少年患者的疾病控制情况。